Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer’s revision identifier was updated from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-21T14:47:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the completed BALANCE-EXTEND upadacitinib study, including its design, outcomes, eligibility criteria, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-07T14:22:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T14:53:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    An NIH-wide announcement banner directs visitors to transition updates and notes that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:36:11.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the study record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:27:19.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:23:38.000Z thumbnail image

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.